KBC Group’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
Other funds holding GMED
KBC Group's GMED Position: Q3 2026 in Review
KBC Group reduced its Globus Medical (GMED) stake by 3.8% in Q3 2026, selling an estimated $220K and leaving 69,924 shares worth $5.24M. The position accounts for 0.01% of the portfolio, ranked #501.
KBC Group first reported a position in GMED in Q2 2022 and has held it in 18 quarters since. The position peaked at $6.41M in Q4 2025. 617 funds tracked by Wall St. Rank hold GMED as of Q3 2026.
- KBC Group held 69,924 shares of Globus Medical worth $5.24M as of Q3 2026.
- KBC Group sold 2,778 Globus Medical shares in Q3 2026, an estimated $220K.
- Globus Medical made up 0.01% of KBC Group's portfolio in Q3 2026, its #501 holding.
- KBC Group first reported a position in Globus Medical in Q2 2022 and has held it in 18 quarters since.
- KBC Group's Globus Medical position peaked at $6.41M in Q4 2025.
- 617 funds tracked by Wall St. Rank held Globus Medical as of Q3 2026.
Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.